SCHEMBL6239619

SCHEMBL6239619

CCOC(=O)C=CC(C)=Cc1ccccc1NS(=O)(=O)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.55
TSHR P16473 2/20 0.55
LMNA P02545 6/20 0.47
MCL1 Q07820 1/20 0.47
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
MAPT P10636 5/20 0.45
MDM2 Q00987 1/20 0.45
ALDH1A1 P00352 5/20 0.45
HTT P42858 3/20 0.45
KDM4E B2RXH2 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6242249 0.84 HDAC1 (0.52) KMT2ATSHRLMNAHDAC3HDAC4
SCHEMBL6237456 0.83 HDAC1 (0.67) KMT2ATSHRLMNAMCL1HDAC3
SCHEMBL6239623 0.83 HDAC1 (0.67) KMT2ATSHRLMNAMCL1HDAC3
SCHEMBL398528 0.75 CYP2C9 (0.51) KMT2ATSHRLMNAHDAC1ALDH1A1
SCHEMBL398530 0.75 CYP2C9 (0.51) KMT2ATSHRLMNAHDAC1ALDH1A1
SCHEMBL18182140 0.74 MEN1 (0.60) KMT2ATSHRLMNAMAPTMDM2
SCHEMBL12259104 0.74 MEN1 (0.60) KMT2ATSHRLMNAMAPTMDM2
SCHEMBL6240458 0.73 HDAC1 (0.68) KMT2ATSHRLMNAHDAC3HDAC4
SCHEMBL1403296 0.73 SNCA (0.61) KMT2ATSHRLMNAALDH1A1HTT
SCHEMBL6170122 0.73 SNCA (0.61) KMT2ATSHRLMNAALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005011661-A1 PHARMACEUTICAL AGENTS UNIVERSITY COLLEGE LONDON (GB) 2005-02-10 WO claimed
WO-2005011661-A1 PHARMACEUTICAL AGENTS UNIVERSITY COLLEGE LONDON (GB) 2005-02-10 WO disclosed